rtuneLeader


![]()




REIMAGINING RESPIRATORY CARE WITH PURPOSE, PRECISION, AND HUMANITY







In a field where every breakthrough can impact lives, true
leadership goes beyond just achieving business goals. It demands a sense of purpose, strong convic on, and a steadfast belief that technology should be a force for good in people's lives. This edi on of “The Most Promising Leaders in Medical Equipment & Devices, 2025” celebrates those remarkable individuals who are transforming healthcare with empathy, bravery, and forward-thinking ideas.
Leading the charge in this exci ng transforma on is Ewald Anger, the CEO of TNI medical AG. He's a true trailblazer whose groundbreaking work has reshaped the standards and possibili es in respiratory care. With over twenty years of experience in medical technology, Ewald has demonstrated me and again that real innova on isn't just about technical complexity; it's about the people it serves and the lives it touches.
His journey, rooted in a strong sense of moral responsibility, scien fic integrity, and genuine compassion, showcases a deep understanding of the intersec on between groundbreaking technology and meaningful purpose. Under his guidance, TNI Medical has made significant strides in high-flow respiratory therapy, focusing on safety, comfort, and human dignity, and establishing new global standards for pa ent-centered care.
At the heart of Ewald's leadership approach is a simple yet powerful idea: listen before you lead. He's built a culture where teamwork sparks innova on, humility drives progress, and every strategic choice starts with a crucial ques on: “Is this in the best interest of the pa ent?” This pa ent-first a tude has helped TNI Medical earn the trust of clinicians, hospitals, and pa ents all around the globe.
Ewald has truly shown what it means to lead in a field where innova on and responsibility go hand in hand, whether it is tackling the challenges of global regula ons or making respiratory therapies more accessible. The merger of TNI medical with the Masimo Group marks a significant milestone, expanding the worldwide availability of life-saving respiratory solu ons.
As the healthcare landscape shi s towards a future that emphasizes personalized, connected, and pa ent-centered care, leaders like Ewald Anger remind us that advancements in medical technology ul mately aim to make a real difference. His journey is not just about professional success; it's a compelling reminder of how innova on driven by purpose can promote healing on a global scale.

EDITORIAL TEAM
Editor-in-chief
Sco Edward
Sales & Marke ng Manager
Lily Hayler
Business Development Manager
Lauren Green, Millie Butler, Rosie Jonas
Business Development Execu ve
Victoria Ma hews, Ashley Tucker
Art and Design Director
Paul Brown
Research Analyst
Robert Smith
Follow US












REIMAGINING RESPIRATORY CARE WITH PURPOSE, PRECISION, AND HUMANITY


Intheworldofmedicaltechnologyanindustrydefined
byrelentlessinnovation,unforgivingregulatory realities,andthedeepmoralweightofhumanhealth fewleadersembodypurpose-driventransformationas clearlyasEwaldAnger,CEOofTNImedicalAG.Formore thantwodecades,Angerhasstoodattheintersectionof science,compassion,andtechnologicalforesight,shapinga newfutureforrespiratorytherapy.Hiscareerisnotmerely aprofessionaltimeline;itisalifelongmissiontobring comfort,dignity,andinnovationtopatientswhorelyon life-enhancingrespiratorysupport.
Anger'sentryintothemedicalequipmentanddevicessector wasnotaccidental,norwasitopportunistic.Fromthe beginning,hegravitatedtowardmedicaltechnologyasa callingdrawnbyitspotentialtocreatemeaningful,lasting impact.“Medicaltechnologyhasalwaysbeenasourceof greatpassion,”heoftenreflects.Earlyinhiscareer,he discoveredwhatwouldbecomeadefiningtruth:whenthe righttechnologyisplacedintherighthands,livescanbe transformed.Thatunderstandingshapednotonlyhis professionaltrajectorybutalsohisleadershipphilosophya blendofclarity,compassion,andunshakeableconviction. Throughouthisjourney,Angerhasworkedwith multidisciplinaryteamsacrosstheevolvinglandscapeof healthcare.Thesecollaborationsreinforcedaprinciplehe stillholdscentraltoday:thebestideasemergewhenleaders listenbeforetheylead.Forhim,effectiveleadershipmeans inspiringpeople,championingcollectiveintelligence,and placinghumanityatthecoreofeverydecision.“Together, wecanachievefarmorethananyindividualcanachieve alone,”hebelievesaperspectivethathasguidedbothhis internalteamsandthebroaderecosystemofclinicians, engineers,andpartnerswhoshapemodernrespiratorycare.
ACompanyBornfromConviction:TheEarlyVisionof TNImedicalAG
ThestoryofTNImedicalAGisanextensionofAnger's personalpassion.Foundedontheconvictionthat respiratorysupportcouldandmustbegentler,more efficient,andmorepatient-centric,thecompanyemerged withasimplebutboldmission:makebreathingeasier throughtechnologyrootedincomfort,safety,andrealworldpracticality.
Fromitsearliestdays,TNImedicalsoughttobreaknew groundinrespiratorytherapy.Insteadofmerelyimproving existingsolutions,Angerenvisioneddevelopingnew pathwaysinnovationsthatwouldaddresspersistent challengeswhileenhancingbothpatientoutcomesanduser

experience.Underhisguidance,thecompanyembraced high-flowrespiratorytherapy,introducingsystemsthat provedbothhighlyeffectiveandremarkablygentle.These solutionsofferedmeasurableimprovementsinpatient comfortandqualityoflife,reshapingclinicalexpectations inhospitalsandhomecarealike.
Everyadvancement,Angerinsists,servesasingular purpose:enhancingthelivesofpatients.Itisaphilosophy thatcontinuestodefinethecompany'scultureandcatalyze itsinnovationpipeline.
Leadingamedicaltechnologyfirmisunlikeleadingany othertypeofbusiness.Thestakesarenotmerelyfinancial theyareprofoundlyhuman.Productsmustmeetexacting regulatorystandardswhileremainingaffordable,intuitive, andadaptabletoconstantlyshiftinghealthcaresystems. Angerembracesthesepressureswithprincipledclarity. Effectiveleadership,hebelieves,requirestrust,empathy, respect,andunwaveringalignmentwithaclearvision.“We remindourselveseverydaythatwearecontributingto patients'livesandhelpingsupporthealthcaresystemsthat relyonsafe,reliable,high-qualitytools,”hesays. Hisleadershipstyleisdefinedbyanopen-doorapproachto innovation.Novoiceistoojunior,noideatoosmall,andno hierarchytoorigid.“Everyideamatters,”heinsists.“The bestideawins.”Thiscultureofcreativityandshared purposehasbeenessentialtoTNI'sabilitytorefine,adapt, andevolvetechnologiesthatresonatedeeplywithclinicians andpatientsalike.
UnderAnger'sleadership,TNImedicalhasbuiltits reputationontechnologiesthatprioritizepatientneeds whilesimplifyingtherapyapplicationforhealthcare professionals.Thecompany'sflagshiphigh-flowtherapy solutionsrepresentamilestoneinmodernrespiratorycare —highlyeffectiveyetnon-invasive,capableofdelivering comfortwithoutcompromisingtherapeuticperformance. Suchinnovations,Angernotes,requiredperseveranceanda willingnesstochallengeassumptions.“Whenweleaveno stoneunturned,solutionscanbefoundevenforchallenges thatonceseemedunsolvable,”hesays.Thatrelentless pursuitofpossibilityhasbecomeahallmarkofthe company'sidentity.
Thepathfromconcepttoclinicisrarelystraightforwardin medicaldevices.Strictregulatoryframeworks,financial

constraints,globaldisparitiesinaccess,andevolving marketexpectationsalldemandresilienceandclarityof purpose.Angerhasnavigatedthesecomplexitiesthrough patience,transparency,andanunwaveringfocusonpatient benefit.
Balancingregulationwithinnovation,heexplains,requires disciplineandlong-termvision.Productsmustembody safety,affordability,andcompliancewithoutsacrificing originalityorimpact.Underhisguidance,TNImedicalhas consistentlyupheldthisequilibrium,ensuringinnovations remainbothgroundbreakingandresponsible.
InsideTNImedical,collaborationisnotmerelyencouraged itisfoundational.Angerviewshisrolenotasthearchitect ofeverysolution,butasthecustodianofanenvironment whereideasflourish.Hesetstheframework,butthe creativecanvasbelongstotheteam.
Thisphilosophyhascultivatedacultureofshared ownership,curiosity,andhumility,whereeachmember understandsthatinnovationisacollectivejourney.Atits centerliesaunifyingpurpose:ensuringthateverydevice, everyimprovement,andeverydecisionultimatelyserves thewell-beingofpatients.
Inanindustrywherelivesdependoneverydesignchoice,




AngerensuresthatTNImedicalseesinnovationnotasa racetooutperformcompetitorsbutasaresponsibilityto elevatestandardsofcare.Closecollaborationwith physicians,respiratorytherapists,andclinicalusersensures eachsolutiondeliversreal-worldvaluesafe,intuitive,and accessible.Technology,heemphasizes,mustdomorethan impressitmustmatter.
TNImedical'sglobalexpansionhasunfoldedsteadilyunder Anger'sstrategicstewardship.Eachnewmarketrepresents asteptowardfulfillingacorebelief:patientseverywhere deserveaccesstomodernrespiratorytherapy
Atransformativemilestonecamewiththecompany's integrationintotheMasimoGroup,unlockingnew distributionchannels,broaderclinicalreach,andan internationalplatformforimpact.Thispartnershiphas acceleratedTNI'spresenceinhospitalsandhomecare settingsworldwide,amplifyingitsmissiononaglobal scale.
Lookingtothefuture,Angerenvisionsrespiratorytherapy becomingmoreinterconnected,morepersonalized,and moreseamlesslyintegratedintodailylife.Hisupcoming innovationsaimtoenhancehome-basedcare,empower patients,reduceburdensonoverstretchedhealthcare systems,andbringatouchofhumanitybackintoadomain oftendominatedbyhardwareandprotocols.Innovation, responsibility,andempathywillremaintheguidingforces ofTNImedical'strajectory.
Foremergingleaders,Angeroffersasimplebutprofound message:pursueyourvisionwithpassionevenwhenthe pathissteep.Medicaltechnologyisafieldrootedinservice tohumanity Thosewhosucceedaredrivennotonlyby technicalbrilliancebutbypurpose,perseverance,anda deeprespectforthelivestheytouch.
IfthereisonethemethatdefinesAnger'sleadership,itishis insistencethatmedicaltechnologyisfundamentallyabout peoplenotdevices,notmarkets,buthumanlives.AtTNI medical,thisbeliefshapeseveryinitiative,every innovation,andeverygoalforthefuture.
WithaleaderlikeEwaldAngeratthehelmvision-driven, collaborative,andprofoundlyhumanTNImedicalAGis notjustshapingrespiratorytherapy.Itisreimaginingwhat compassionateinnovationinhealthcarecantrulylooklike.




Theglobalmedicaldevicesmarketisontrackfor
impressivegrowth,fueledbycutting-edge technology,increasedinvestmentsinhealthcare, andagrowingneedforsophisticateddiagnosticand treatmenttools.Expertspredictthatthismarketcould surpass$800billionby2030,thankstothestrongpushin digitalhealth,wearabletech,andminimallyinvasive devices.
Thegrowthoftheindustryisbeingdrivenbychangesin demographics,likeanagingpopulationandtheincreasing ratesofchronicillnessessuchasdiabetesandheartdisease. Thesetrendsareencouragingbothhealthcaresystemsand consumerstoembracesmarter,data-drivenapproachesfor preventionandmonitoring.
Theintegrationofartificialintelligence(AI)andthe InternetofThings(IoT)isreallyshakingthingsupinthe healthcaresector.Morecompaniesareaddingsensorsand connectivityfeaturestotraditionalmedicaldevices,which allowsforcontinuousdatacollectionandpredictive analytics.Thischangeisnotonlyimprovingearlydiagnosis andtreatmentaccuracybutalsocuttingdownonhospital visitsahugebenefitforhealthcaresystemsthatarenow morefocusedonefficiencyandcostsavingsinthewakeof thepandemic.








ArtificialIntelligenceisswiftlyreshapingthehealthcarelandscape,
fundamentallychangingtheprocessesofdiagnostics,treatment planning,andpatientmonitoring.Throughtheutilizationof sophisticatedalgorithmsandmachinelearningmethodologies,AIis increasingtheefficiencyandprecisionofmedicalpractices,thereby enhancingpatientoutcomes,andstreamlininghealthcaredelivery
AI’smostsignificantinfluenceiscurrentlyobservedintherealmof diagnostics.Machinelearningalgorithmspossessthecapabilitytoscrutinize extensivevolumesofmedicaldata,includingmedicalimaging,laboratory results,andpatienthistories,touncoverpatternsthatmayeludehuman practitioners.Forinstance,AItechnologiesareemployedtodetectearly indicatorsofdiseasessuchascancer,cardiovascularissues,andneurological conditionsthroughmedicalimaging.Thesesystemscanidentifysubtle irregularitiesinX-rays,CTscans,MRIs,andvariousotherimaging techniques,frequentlyachievinghigheraccuracyandspeedthanhuman specialists.AI-enhanceddiagnosticsystems,particularlyinradiology,are alreadyassistingphysiciansindeliveringquickerandmoreprecisediagnoses, whichfacilitatesearlierinterventionsandimprovespatientoutcomes.
AIistransformingtreatmentplanningbydeliveringpersonalizedcarethat alignswiththedistinctattributesofeachpatient.Inthefieldofoncology,for example,AIalgorithmsevaluategeneticinformation,tumorfeatures,and patientmedicalhistorytosuggestthemostsuitabletreatmentalternatives. Thistailoredmethodology,referredtoasprecisionmedicine,allows healthcareproviderstoselecttheoptimaltreatmentplan,enhancing effectivenesswhileminimizingsideeffects.Likewise,AI-drivendecision supportsystemsinspecialtiessuchascardiologyandorthopedicsassist cliniciansinformulatingtreatmentstrategiesbyconsideringvariousfactors, includingthepatient’smedicalbackground,lifestylechoices,andreactionsto priortreatments.

AIalsoplaysasignificantroleinenhancingthedrug developmentprocess.Byutilizingmachinelearning models,researcherscanforecasttheinteractionsofvarious compoundswithdiseasepathways.Thiscapabilityallows foramorerapididentificationofnewmedicationsand therapies,potentiallyexpeditingtheintroductionoflifesavingdrugstothemarket,especiallyforrareorcomplex diseases.
AIissignificantlyimprovingpatientmonitoring,especially inthemanagementofchronicillnesses.Wearable technologyandintelligentdevicesthatutilizeAIalgorithms arecapableofcontinuouslymonitoringvitalsigns, includingheartrate,bloodpressure,andglucoselevels.
professionalstotakepreventivemeasuresbeforeconditions escalate.Furthermore,AI-drivenpredictiveanalyticsare beingemployedtoanticipatepatientdecline,facilitating promptinterventionsinintensivecareunits(ICUs)and emergencysituations.
Theincorporationofartificialintelligenceintodiagnostics, treatmentplanning,andpatientmonitoringenables healthcaresystemstoprovidecarethatismoreprecise, individualized,andefficient.AsAItechnologyadvances,its capacitytoenhancepatientoutcomesandlowerhealthcare expensesissubstantial,influencingthetrajectoryof contemporarymedicine.





